FEATURE ARTICLES
Are you ready? FDA has begun to implement the use of artificial intelligence in its operations, particularly during inspection activities.
- Chugai Accelerates Automation To Boost Operational Efficiency
- The Future Of Continuous Is Integrated Manufacturing: The 4 Misconceptions About A Lean Process
- CDMO Selection: Start With The Relationship, Not The RFP
- Why FAT Should Confirm Alignment, Not Reveal Its Absence
- What Reliance, Annex 1, And AI Mean For The Future Of GMP
- Applying Contamination Control By Design: A Practical Guide For CDMOs
- Navigating Rough Pharma Seas With Collaboration
PHARMA ONLINE WHITE PAPERS
-
A Supplier-Manufacturer Approach To Mitigating Nitrosamine Risk
Learn about how nitrosamines are formed, their prevalence and chemical precursors in pharmaceuticals, techniques for quantification, and approaches for managing nitrite impurities.
-
A Patented Process For Intermediates Useful For Upadacitinib2/18/2026
Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.
-
Building Excellence In Pharma Manufacturing Through Rigor8/16/2025
A rigorous, proactive approach is essential for excellence in pharmaceutical manufacturing. Learn how embedding rigor in systems, workflows, and workforce capabilities improves compliance and efficiency.
-
Why Biopharma Breakthroughs Aren't Moving The Market10/20/2025
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
Mixing Technologies For The Production Of Low To High Viscosity Adhesives4/28/2026
Understand how high shear and planetary mixing technologies optimize adhesive production. Learn to reduce cycle times, eliminate defects, and balance efficiency with your specific viscosity needs.
-
Criteria For Effective Bioprocess Scale-Up3/25/2026
Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
- Development Of A High Sensitivity SPE-LC-MS/MS Assay
- Part 1: Intuitive Bioprocess Scale-Up From Bench Scale To Pilot Scale
- Enhanced Flow Kit Performance With Leak And PUPSIT Testing
- Bioanalytical Quantification Of A Biotherapeutic Peptide
NEWSLETTER ARCHIVE
- 06.09.26 -- CDMO Capabilities for Biologics And HPAPI Manufacturing
- 06.09.26 -- Rethinking CQV In A Digital, Agile Manufacturing Landscape
- 06.05.26 -- Process Equipment Spotlight: Lab Advances Innovations
- 06.04.26 -- From Partnerships To RNA: Trends Redefining Biopharma
- 06.04.26 -- Closing The MES Value Gap: Why Technology Isn't The Problem
INDUSTRY NEWS
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
9 Drugs Granted Fast Track By FDA's Voucher Program
With targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
Leaders In The Excipient Market: Region And Type
Though North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
Pfizer Strengthens Obesity Foothold With Metsera Acquisition
After discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Veranova Appoints Dr. Bob Huang Vice President And General Manager Of West Deptford Site6/3/2026
Veranova today announced the appointment of Dr. Bob Huang as Vice President and General Manager for its West Deptford, New Jersey facility. He will lead site operations, advance strategic growth initiatives, and strengthen manufacturing excellence and customer delivery.